Document is current
Any future updates will be listed below
-
Authors
Núñez-Jurado, David
Fernández-Vega, Alejandro
del Río, Carmen
Penalba, Anna
Llucià-Carol, Laia
Muiño-Acuña, Elena
Ezcurra-Díaz, Garbiñe
Guasch-Jiménez, Marina
Cullell, Natalia
Serrano-Heras, Gemma
Arias-Salazar, Lourdes
Vives-Bauza, Cristòfol
Tur, Silvia
Urra, Xabier
Castellanos, Mar
Krupinski, Jerzy
Freijo-Guerrero, Marimar
Jiménez-Conde, Jordi
Fernández-Pérez, Isabel
Segura, Tomás
Marti-Fabregas, Joan
Férnandez-Cadenas, Israel
Montaner, Joan
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (CM23/00216, PMP21/00165, PMP21/00165, PMP21/00165)
Ministerio de Universidades (POLIFENEV)
- License Information
-
More Information
Article History
Received: 15 July 2025
Accepted: 22 September 2025
First Online: 28 October 2025
Declarations
:
: The study was initiated at the Hospital de la Santa Creu i Sant Pau, Barcelona, and approved by its Research Ethics Committee on Medicines (reference IIBSP-PRE-2022-39). The hospital also acted as the coordinating center for the multicenter study. Each participating center obtained approval from its respective local ethics committee. Written informed consent was obtained from all participants or their legal representatives.
: Not applicable.
: The authors declare no competing interests.
